Urinary miRNAs and Prostate Cancer: Is there a Crossover Point Eventually, and where should we Head?


Cite item

Full Text

About the authors

Ilias Giannakodimos

Department of Urology, National and Kapodistrian University of Athens, Athens

Author for correspondence.
Email: info@benthamscience.net

References

  1. Payne, H.; Cornford, P. Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer. Urol. Oncol., 2011, 29(6), 593-601. doi: 10.1016/j.urolonc.2009.11.003 PMID: 20060331
  2. Roehrborn, C.G. The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia. Int. J. Impot. Res., 2008, 20(S3)(Suppl. 3), S19-S26. doi: 10.1038/ijir.2008.53 PMID: 19002120
  3. O’Shea, A.; Harisinghani, M. PI-RADS: Multiparametric MRI in prostate cancer. Magn. Reson. Mater. Biol. Phys. Med., 2022, 35(4), 523-532. doi: 10.1007/s10334-022-01019-1 PMID: 35596009
  4. Yoneyama, T.; Tobisawa, Y.; Kaneko, T.; Kaya, T.; Hatakeyama, S.; Mori, K.; Sutoh Yoneyama, M.; Okubo, T.; Mitsuzuka, K.; Duivenvoorden, W.; Pinthus, J.H.; Hashimoto, Y.; Ito, A.; Koie, T.; Suda, Y.; Gardiner, R.A.; Ohyama, C. Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection. Cancer Sci., 2019, 110(8), 2573-2589. doi: 10.1111/cas.14082 PMID: 31145522
  5. Ziogou, A.; Giannakodimos, A.; Giannakodimos, I. The role of urinary miRNAs in the diagnosis, management and follow-up of prostatic cancer. MicroRNA, 2023, 12(2), 83-86. doi: 10.2174/2211536612666230324102850 PMID: 36999432
  6. Giannakodimos, I. Urinary miRNAs as diagnostic biomarkers for prostatic cancer: Current dilemmas and novel potential role for a digital rectal examination. Curr. Med. Chem., 2022, 29(25), 4311-4313. doi: 10.2174/0929867329666220118101733 PMID: 35040397
  7. Paiva, R.M.; Zauli, D.A.G.; Neto, B.S.; Brum, I.S. Urinary microRNAs expression in prostate cancer diagnosis: A systematic review. Clin. Transl. Oncol., 2020, 22(11), 2061-2073. doi: 10.1007/s12094-020-02349-z PMID: 32323148
  8. Casanova-Salas, I.; Rubio-Briones, J.; Calatrava, A.; Mancarella, C.; Masiá, E.; Casanova, J.; Fernández-Serra, A.; Rubio, L.; Ramírez-Backhaus, M.; Armiñán, A.; Domínguez-Escrig, J.; Martínez, F.; García-Casado, Z.; Scotlandi, K.; Vicent, M.J.; López-Guerrero, J.A. Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy. J. Urol., 2014, 192(1), 252-259. doi: 10.1016/j.juro.2014.01.107 PMID: 24518785
  9. Aveta, A.; Cilio, S.; Contieri, R.; Spena, G.; Napolitano, L.; Manfredi, C.; Franco, A.; Crocerossa, F.; Cerrato, C.; Ferro, M.; Del Giudice, F.; Verze, P.; Lasorsa, F.; Salonia, A.; Nair, R.; Walz, J.; Lucarelli, G.; Pandolfo, S.D. Urinary MicroRNAs as biomarkers of urological cancers: A systematic review. Int. J. Mol. Sci., 2023, 24(13), 10846. doi: 10.3390/ijms241310846 PMID: 37446024

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers